Balyasny Asset Management »

Neuphoria Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $579k 142k 4.07

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Neuphoria Therapeutics

Lynx1 Capital Management
AdvisorShares Investments
Shay Capital
Balyasny Asset Management
Squadron Capital Management
Geode Capital Management
Diadema Partners
Ikarian Capital
Vanguard Fiduciary Trust
ADAR1 Capital Management
FNY Investment Advisers
Vanguard Group
Citadel Advisors
Bridgeway Capital Management
Boothbay Fund Management

View all funds holding Neuphoria Therapeutics